CN Stock MarketDetailed Quotes

000952 Hubei Guangji Pharmaceutical

Watchlist
  • 5.36
  • -0.19-3.42%
Market Closed Oct 11 15:00 CST
1.88BMarket Cap-8481P/E (TTM)

Hubei Guangji Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-13.80%296.46M
56.27%180.16M
-7.50%737.82M
-2.57%522.49M
-8.54%343.91M
-13.49%115.29M
1.54%797.64M
12.59%536.28M
16.30%376.02M
-24.42%133.27M
Operating revenue
-13.80%296.46M
56.27%180.16M
-7.50%737.82M
-2.57%522.49M
-8.54%343.91M
-13.49%115.29M
1.54%797.64M
12.59%536.28M
16.30%376.02M
-24.42%133.27M
Other operating revenue
71.09%7.47M
----
176.27%7.71M
----
2,850.02%4.37M
----
494.89%2.79M
----
-82.77%147.98K
----
Total operating cost
9.95%404.57M
49.09%239.27M
15.00%862.66M
11.88%591.55M
2.42%367.96M
19.43%160.48M
6.34%750.16M
26.16%528.71M
26.37%359.25M
-15.47%134.38M
Operating cost
-6.68%222.07M
59.92%150.66M
6.58%535.62M
6.19%371.86M
-5.46%237.97M
4.36%94.21M
3.76%502.53M
24.92%350.19M
24.87%251.71M
-23.15%90.27M
Operating tax surcharges
-2.72%6.69M
-13.02%3.54M
1.39%13.69M
0.14%9.94M
1.16%6.87M
18.84%4.07M
-15.45%13.5M
-16.66%9.93M
-18.35%6.79M
-14.64%3.42M
Operating expense
-13.08%19.41M
6.88%10.44M
15.03%38.64M
24.84%29.03M
37.71%22.33M
106.17%9.76M
10.87%33.59M
49.22%23.25M
72.96%16.21M
-15.22%4.74M
Administration expense
66.78%103.07M
62.31%50.22M
34.24%156.19M
21.67%104.42M
25.02%61.8M
40.02%30.94M
8.74%116.35M
20.10%85.82M
23.52%49.43M
2.93%22.1M
Financial expense
110.27%24.91M
64.06%8.32M
187.73%43.77M
244.53%27.36M
104.81%11.85M
8.67%5.07M
-3.64%15.21M
-26.67%7.94M
-9.86%5.79M
59.45%4.67M
-Interest expense (Financial expense)
90.48%29.15M
68.45%9.34M
132.93%49.15M
124.88%31.93M
62.52%15.31M
16.67%5.54M
26.29%21.1M
21.75%14.2M
38.15%9.42M
60.96%4.75M
-Interest Income (Financial expense)
30.76%-1.05M
-11.52%-613.08K
-72.70%-3.46M
-78.39%-2.45M
-60.43%-1.51M
-29.12%-549.77K
37.90%-2M
39.05%-1.37M
27.11%-943.52K
36.16%-425.79K
Research and development
4.73%28.42M
-2.05%16.1M
8.37%74.75M
-5.11%48.94M
-7.45%27.14M
78.90%16.43M
32.49%68.98M
77.99%51.57M
57.76%29.32M
22.37%9.19M
Credit Impairment Loss
84.70%-618.03K
-352.74%-1.25M
99.38%-27.48K
27.34%-3.33M
-25.44%-4.04M
243.16%492.63K
-327.64%-4.45M
-206.87%-4.59M
-167.05%-3.22M
71.72%-344.1K
Asset Impairment Loss
-570.96%-12.61M
-190.29%-741.26K
-85.55%-14.26M
254.61%2.32M
310.08%2.68M
139.65%821.01K
-148.47%-7.69M
114.11%652.85K
123.72%652.85K
-689.73%-2.07M
Other net revenue
-101.12%-7.94M
2,863.21%2.92M
-221.95%-16.22M
-140.99%-4.37M
-138.51%-3.95M
-101.08%-105.76K
-65.06%13.3M
-57.90%10.65M
-62.03%10.26M
1,724.39%9.84M
Invest income
42.59%-2.92M
71.36%-855.48K
-259.03%-10.02M
-241.43%-6.99M
-209.47%-5.09M
-150.83%-2.99M
-66.34%6.3M
-73.72%4.94M
-75.50%4.65M
580.51%5.88M
-Including: Investment income associates
70.83%-1.49M
71.36%-855.48K
-305.89%-8.93M
-266.08%-6.99M
-215.80%-5.09M
-147.99%-2.99M
-74.71%4.34M
-75.93%4.21M
-75.64%4.4M
467.08%6.22M
Asset deal income
----
--84.38K
105.88%253.34K
----
----
--0
-891.92%-4.31M
----
----
---9.62K
Other revenue
227.22%8.21M
262.32%5.68M
-66.52%7.85M
-62.23%3.64M
-69.30%2.51M
-75.44%1.57M
17.55%23.43M
41.33%9.65M
36.90%8.17M
96.98%6.38M
Operating profit
-314.56%-116.06M
-24.04%-56.19M
-332.07%-141.05M
-502.90%-73.42M
-203.61%-28M
-618.97%-45.3M
-48.58%60.78M
-77.92%18.22M
-59.08%27.02M
-51.23%8.73M
Add:Non operating Income
8,019.56%1.06M
350,685.78%1.07M
33.21%1.2M
1.99%916.89K
-97.15%13.06K
-99.85%306
-86.20%899.42K
-6.89%898.98K
9,059.77%457.99K
4,059.76%207.99K
Less:Non operating expense
-96.02%25.68K
-82.38%91.67K
-49.22%811.45K
-50.85%717.04K
-48.23%645.47K
-57.59%520.16K
322.34%1.6M
460.81%1.46M
2,798.16%1.25M
3,566.18%1.23M
Total profit
-301.79%-115.02M
-20.49%-55.2M
-334.12%-140.67M
-514.53%-73.22M
-209.14%-28.63M
-694.28%-45.82M
-51.68%60.08M
-78.78%17.66M
-60.25%26.23M
-56.85%7.71M
Less:Income tax cost
207.72%540.49K
-27.45%-535.01K
-5.25%11.75M
-133.40%-1.42M
-116.76%-501.75K
-872.81%-419.79K
-33.09%12.4M
-104.89%-610.16K
-63.19%2.99M
-98.90%54.32K
Net profit
FPtoL-115.56M
FPtoL-54.67M
SL-152.41M
SL-71.79M
SL-28.13M
SL-45.4M
-54.93%47.68M
-74.18%18.27M
-59.84%23.24M
-40.82%7.66M
Net profit from continuing operation
-310.88%-115.56M
-20.42%-54.67M
-419.63%-152.41M
-492.90%-71.79M
-221.04%-28.13M
-693.01%-45.4M
-54.93%47.68M
-74.18%18.27M
-59.84%23.24M
-40.82%7.66M
Less:Minority Profit
-284.21%-8.92M
-206.02%-4.16M
-359.16%-12.17M
-194.82%-4.82M
-59.13%-2.32M
-94.09%-1.36M
38.37%-2.65M
52.23%-1.63M
21.73%-1.46M
22.40%-700.59K
Net profit of parent company owners
-313.28%-106.65M
-14.69%-50.51M
-378.64%-140.25M
-436.44%-66.98M
-204.49%-25.8M
-627.02%-44.04M
-54.29%50.33M
-73.16%19.91M
-58.65%24.7M
-39.62%8.36M
Earning per share
Basic earning per share
-313.44%-0.3014
-14.71%-0.1427
-376.48%-0.3962
-435.46%-0.1892
-203.70%-0.0729
-611.93%-0.1244
-55.23%0.1433
-73.84%0.0564
-59.50%0.0703
-56.29%0.0243
Diluted earning per share
-313.44%-0.3014
-14.71%-0.1427
-376.24%-0.3942
-427.90%-0.1892
-201.82%-0.0729
-624.89%-0.1244
-55.42%0.1427
-73.24%0.0577
-58.76%0.0716
-57.37%0.0237
Other composite income
-125.92%-4.5K
-265.79%-4.54K
116.26%13.97K
154.63%6.19K
263.92%17.36K
136.05%2.74K
111.95%6.46K
67.18%-11.33K
52.85%-10.59K
-7.59K
Other composite income of parent company owners
-125.92%-4.5K
-265.79%-4.54K
116.26%13.97K
154.63%6.19K
263.92%17.36K
136.05%2.74K
111.95%6.46K
67.18%-11.33K
52.85%-10.59K
---7.59K
Total composite income
-311.15%-115.57M
-20.44%-54.67M
-419.56%-152.4M
-493.11%-71.79M
-221.02%-28.11M
-693.56%-45.4M
-54.90%47.69M
-74.18%18.26M
-59.84%23.23M
-40.88%7.65M
Total composite income of parent company owners
-313.58%-106.65M
-14.71%-50.51M
-378.57%-140.23M
-436.60%-66.97M
-204.46%-25.79M
-627.46%-44.04M
-54.26%50.34M
-73.17%19.9M
-58.65%24.69M
-39.67%8.35M
Total composite income of minority owners
-284.21%-8.92M
-206.02%-4.16M
-359.16%-12.17M
-194.82%-4.82M
-59.13%-2.32M
-94.09%-1.36M
38.37%-2.65M
52.23%-1.63M
21.73%-1.46M
22.40%-700.59K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -13.80%296.46M56.27%180.16M-7.50%737.82M-2.57%522.49M-8.54%343.91M-13.49%115.29M1.54%797.64M12.59%536.28M16.30%376.02M-24.42%133.27M
Operating revenue -13.80%296.46M56.27%180.16M-7.50%737.82M-2.57%522.49M-8.54%343.91M-13.49%115.29M1.54%797.64M12.59%536.28M16.30%376.02M-24.42%133.27M
Other operating revenue 71.09%7.47M----176.27%7.71M----2,850.02%4.37M----494.89%2.79M-----82.77%147.98K----
Total operating cost 9.95%404.57M49.09%239.27M15.00%862.66M11.88%591.55M2.42%367.96M19.43%160.48M6.34%750.16M26.16%528.71M26.37%359.25M-15.47%134.38M
Operating cost -6.68%222.07M59.92%150.66M6.58%535.62M6.19%371.86M-5.46%237.97M4.36%94.21M3.76%502.53M24.92%350.19M24.87%251.71M-23.15%90.27M
Operating tax surcharges -2.72%6.69M-13.02%3.54M1.39%13.69M0.14%9.94M1.16%6.87M18.84%4.07M-15.45%13.5M-16.66%9.93M-18.35%6.79M-14.64%3.42M
Operating expense -13.08%19.41M6.88%10.44M15.03%38.64M24.84%29.03M37.71%22.33M106.17%9.76M10.87%33.59M49.22%23.25M72.96%16.21M-15.22%4.74M
Administration expense 66.78%103.07M62.31%50.22M34.24%156.19M21.67%104.42M25.02%61.8M40.02%30.94M8.74%116.35M20.10%85.82M23.52%49.43M2.93%22.1M
Financial expense 110.27%24.91M64.06%8.32M187.73%43.77M244.53%27.36M104.81%11.85M8.67%5.07M-3.64%15.21M-26.67%7.94M-9.86%5.79M59.45%4.67M
-Interest expense (Financial expense) 90.48%29.15M68.45%9.34M132.93%49.15M124.88%31.93M62.52%15.31M16.67%5.54M26.29%21.1M21.75%14.2M38.15%9.42M60.96%4.75M
-Interest Income (Financial expense) 30.76%-1.05M-11.52%-613.08K-72.70%-3.46M-78.39%-2.45M-60.43%-1.51M-29.12%-549.77K37.90%-2M39.05%-1.37M27.11%-943.52K36.16%-425.79K
Research and development 4.73%28.42M-2.05%16.1M8.37%74.75M-5.11%48.94M-7.45%27.14M78.90%16.43M32.49%68.98M77.99%51.57M57.76%29.32M22.37%9.19M
Credit Impairment Loss 84.70%-618.03K-352.74%-1.25M99.38%-27.48K27.34%-3.33M-25.44%-4.04M243.16%492.63K-327.64%-4.45M-206.87%-4.59M-167.05%-3.22M71.72%-344.1K
Asset Impairment Loss -570.96%-12.61M-190.29%-741.26K-85.55%-14.26M254.61%2.32M310.08%2.68M139.65%821.01K-148.47%-7.69M114.11%652.85K123.72%652.85K-689.73%-2.07M
Other net revenue -101.12%-7.94M2,863.21%2.92M-221.95%-16.22M-140.99%-4.37M-138.51%-3.95M-101.08%-105.76K-65.06%13.3M-57.90%10.65M-62.03%10.26M1,724.39%9.84M
Invest income 42.59%-2.92M71.36%-855.48K-259.03%-10.02M-241.43%-6.99M-209.47%-5.09M-150.83%-2.99M-66.34%6.3M-73.72%4.94M-75.50%4.65M580.51%5.88M
-Including: Investment income associates 70.83%-1.49M71.36%-855.48K-305.89%-8.93M-266.08%-6.99M-215.80%-5.09M-147.99%-2.99M-74.71%4.34M-75.93%4.21M-75.64%4.4M467.08%6.22M
Asset deal income ------84.38K105.88%253.34K----------0-891.92%-4.31M-----------9.62K
Other revenue 227.22%8.21M262.32%5.68M-66.52%7.85M-62.23%3.64M-69.30%2.51M-75.44%1.57M17.55%23.43M41.33%9.65M36.90%8.17M96.98%6.38M
Operating profit -314.56%-116.06M-24.04%-56.19M-332.07%-141.05M-502.90%-73.42M-203.61%-28M-618.97%-45.3M-48.58%60.78M-77.92%18.22M-59.08%27.02M-51.23%8.73M
Add:Non operating Income 8,019.56%1.06M350,685.78%1.07M33.21%1.2M1.99%916.89K-97.15%13.06K-99.85%306-86.20%899.42K-6.89%898.98K9,059.77%457.99K4,059.76%207.99K
Less:Non operating expense -96.02%25.68K-82.38%91.67K-49.22%811.45K-50.85%717.04K-48.23%645.47K-57.59%520.16K322.34%1.6M460.81%1.46M2,798.16%1.25M3,566.18%1.23M
Total profit -301.79%-115.02M-20.49%-55.2M-334.12%-140.67M-514.53%-73.22M-209.14%-28.63M-694.28%-45.82M-51.68%60.08M-78.78%17.66M-60.25%26.23M-56.85%7.71M
Less:Income tax cost 207.72%540.49K-27.45%-535.01K-5.25%11.75M-133.40%-1.42M-116.76%-501.75K-872.81%-419.79K-33.09%12.4M-104.89%-610.16K-63.19%2.99M-98.90%54.32K
Net profit FPtoL-115.56MFPtoL-54.67MSL-152.41MSL-71.79MSL-28.13MSL-45.4M-54.93%47.68M-74.18%18.27M-59.84%23.24M-40.82%7.66M
Net profit from continuing operation -310.88%-115.56M-20.42%-54.67M-419.63%-152.41M-492.90%-71.79M-221.04%-28.13M-693.01%-45.4M-54.93%47.68M-74.18%18.27M-59.84%23.24M-40.82%7.66M
Less:Minority Profit -284.21%-8.92M-206.02%-4.16M-359.16%-12.17M-194.82%-4.82M-59.13%-2.32M-94.09%-1.36M38.37%-2.65M52.23%-1.63M21.73%-1.46M22.40%-700.59K
Net profit of parent company owners -313.28%-106.65M-14.69%-50.51M-378.64%-140.25M-436.44%-66.98M-204.49%-25.8M-627.02%-44.04M-54.29%50.33M-73.16%19.91M-58.65%24.7M-39.62%8.36M
Earning per share
Basic earning per share -313.44%-0.3014-14.71%-0.1427-376.48%-0.3962-435.46%-0.1892-203.70%-0.0729-611.93%-0.1244-55.23%0.1433-73.84%0.0564-59.50%0.0703-56.29%0.0243
Diluted earning per share -313.44%-0.3014-14.71%-0.1427-376.24%-0.3942-427.90%-0.1892-201.82%-0.0729-624.89%-0.1244-55.42%0.1427-73.24%0.0577-58.76%0.0716-57.37%0.0237
Other composite income -125.92%-4.5K-265.79%-4.54K116.26%13.97K154.63%6.19K263.92%17.36K136.05%2.74K111.95%6.46K67.18%-11.33K52.85%-10.59K-7.59K
Other composite income of parent company owners -125.92%-4.5K-265.79%-4.54K116.26%13.97K154.63%6.19K263.92%17.36K136.05%2.74K111.95%6.46K67.18%-11.33K52.85%-10.59K---7.59K
Total composite income -311.15%-115.57M-20.44%-54.67M-419.56%-152.4M-493.11%-71.79M-221.02%-28.11M-693.56%-45.4M-54.90%47.69M-74.18%18.26M-59.84%23.23M-40.88%7.65M
Total composite income of parent company owners -313.58%-106.65M-14.71%-50.51M-378.57%-140.23M-436.60%-66.97M-204.46%-25.79M-627.46%-44.04M-54.26%50.34M-73.17%19.9M-58.65%24.69M-39.67%8.35M
Total composite income of minority owners -284.21%-8.92M-206.02%-4.16M-359.16%-12.17M-194.82%-4.82M-59.13%-2.32M-94.09%-1.36M38.37%-2.65M52.23%-1.63M21.73%-1.46M22.40%-700.59K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data